Professionals like doctors and pharmacists are often caught in the middle, sometimes accused of enabling those addicted to these drugs by provided continued access via subscriptions. Yet, those accusations typically ignore the immense challenges faced by healthcare providers when trying to navigate the complex rules and regulations related to drug monitoring.